CHMP recommends approval of Ontozry for focal – onset (partial-onset) seizures – SK Biopharmaceuticals
SK Biopharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use.
SK Biopharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use.
A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in… read more.
A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens
Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration… read more.
Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.
A simple eye exam combined with powerful artificial intelligence (AI) machine learning technology could provide early detection of Parkinson’s disease, according to research being presented at the annual… read more.
A survey of more than 4,000 UK emergency care doctors has shown that they need more support to recover from work pressures between shifts.
Article written by Christine Clark A bacteriophage-loaded hydrogel proved to be effective treatment for a chronically infected knee prosthesis, according to Thomas Briot and colleagues (Red Cross Hospital,… read more.
The feasibility of 3D printing and using amiodarone tablets was explored by Ian Soulairol and colleagues at the University Hospital of Nîmes.
Article written by Christine Clark Storage of drug products at ultra-low temperatures calls for understanding of the special risks involved…
Article written By Laurence Goldberg Researchers at Massachusetts Institute of Technology (MIT) have developed an artificial intelligence (AI) model that can distinguish between asymptomatic people with covid-19 and… read more.
Article written by Bruce Sylvester Combination treatment of COVID-19 patients with the antiinflammatory, arthritis drug baricitinib plus the antiviral drug remdesivir was superior to remdesivir monotherapy for cutting… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.